Qube Research & Technologies LTD Repligen Corp Transaction History

Qube Research & Technologies LTD

$65.7 Billion
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$170.78 - $208.42 $64,896 - $79,199	-380 Reduced 10.11%	3,377 $621,000
Q4 2023 Feb 13, 2024	BUY	$114.17 - $185.35 $366,029 - $594,232	3,206 Added 581.85%	3,757 $675,000
Q3 2023 Nov 13, 2023	SELL	$138.78 - $176.51 $473,656 - $602,428	-3,413 Reduced 86.1%	551 $87,000
Q2 2023 Aug 14, 2023	BUY	$138.42 - $180.31 $382,592 - $498,376	2,764 Added 230.33%	3,964 $560,000
Q1 2023 May 15, 2023	BUY	$154.26 - $198.1 $185,112 - $237,720	1,200 New	1,200 $202,000
Q3 2022 Nov 14, 2022	BUY	$160.42 - $256.21 $1.15 Million - $1.84 Million	7,170 New	7,170 $1.34 Million
Q2 2022 Aug 15, 2022	SELL	$140.68 - $188.02 $2.75 Million - $3.67 Million	-19,538 Closed	0 $0
Q1 2022 May 09, 2022	SELL	$161.19 - $257.96 $1.72 Million - $2.75 Million	-10,670 Reduced 35.32%	19,538 $3.68 Million
Q4 2021 Feb 01, 2022	BUY	$247.59 - $304.47 $3.52 Million - $4.33 Million	14,213 Added 88.86%	30,208 $8 Million
Q3 2021 Nov 12, 2021	SELL	$194.77 - $324.21 $2.61 Million - $4.35 Million	-13,408 Reduced 45.6%	15,995 $4.62 Million
Q2 2021 Aug 13, 2021	BUY	$165.87 - $220.95 $4.88 Million - $6.5 Million	29,403 New	29,403 $5.87 Million
Q1 2021 May 14, 2021	SELL	$180.37 - $226.26 $1.84 Million - $2.31 Million	-10,222 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$148.08 - $206.57 $3.15 Million - $4.4 Million	-21,294 Reduced 67.57%	10,222 $1.96 Million
Q3 2020 Nov 12, 2020	SELL	$122.51 - $158.27 $198,343 - $256,239	-1,619 Reduced 4.89%	31,516 $4.65 Million
Q2 2020 Aug 14, 2020	BUY	$94.33 - $140.48 $3.13 Million - $4.65 Million	33,135 New	33,135 $4.1 Million

Others Institutions Holding RGEN

# of Institutions

488

Shares Held

54.2M

Call Options Held

341K

Put Options Held

235K

Black Rock Inc. New York, NY

7.57M
Shares

$1.17 Billion
0.02% of portfolio
Price T Rowe Associates Inc Baltimore, MD

6.39M
Shares

$990 Million
0.11% of portfolio
Vanguard Group Inc Valley Forge, PA

5.04M
Shares

$781 Million
0.01% of portfolio
State Street Corp Boston, MA

1.62M
Shares

$251 Million
0.01% of portfolio
Champlain Investment Partners, LLC Burlington, VT

1.42M
Shares

$220 Million
1.34% of portfolio

View Full List

About REPLIGEN CORP

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $8.59B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

More about RGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.

Account